TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock
$13,79
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 11, 2026
Zakres 52 tyg.
$12–$70
4% of range
Ocena Analityków
BUY
8 analysts
Cena Docelowa
$46
+235% upside
P/E (TTM)
-1.1
ROE
-60.0%
Marża Zysku Netto
-946.2%
TNXP Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$13.79
Kapitalizacja Rynkowa
$200M
P/E (TTM)
-1.1
EPS (TTM)
$-14.57
Przychody (TTM)
$13M
Stopa dywidendy
—
ROE
-60.0%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$12 – $70
TNXP Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$13M
2023-12-31
→
2025-12-31
EPS
$-14.57
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-103M
2017-12-31
→
2025-12-31
Marże
-946.2%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
TNXP
Mediana porównawcza
P/E (TTM)
-1.1
2.4
P/S (TTM)
15.2
15.2
P/B
0.8
1.4
Price / FCF (Cena / FCF)
-1.9
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
TNXP
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-959.1%
—
Net Profit Margin (Marża Zysku Netto)
-946.2%
-946.2%
ROA
-56.4%
-52.8%
ROE
-60.0%
-60.2%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
TNXP
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
7.4
7.4
Quick Ratio (Wskaźnik Szybkości)
6.9
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
TNXP
Mediana porównawcza
Revenue YoY (Przychody R/R)
29.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
TNXP
Mediana porównawcza
TNXP Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
8 analityków
- Mocne kupno 2 25,0%
- Kup 5 62,5%
- Trzymaj 1 12,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
4 analityków · 2026-05-18
Mediana
$49.00
← Poniżej wszystkich celów
$13.79
Niski
$22.00
Wysoki
$65.00
Średni cel
$49.00
+255,3%
Średnia cel
$46.25
+235,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.25%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-2.93 | $-2.48 | -0.45% |
| 31 grudnia 2025 | $-3.98 | $-3.25 | -0.73% |
| 30 września 2025 | $-3.59 | $-3.66 | 0.07% |
| 30 czerwca 2025 | $-3.86 | $-3.28 | -0.58% |
| 31 marca 2025 | $-2.84 | $-3.29 | 0.45% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| AVXL | $771M | -16.5 | -36.1% | -991.4% | -47.7% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | — |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $13M | $10M | $8M | |
| Cost of Revenue | $7M | $8M | $5M | |
| R&D Expense | $44M | $40M | $87M | |
| SG&A Expense | $88M | $40M | $35M | |
| Operating Expenses | $139M | $147M | $126M | |
| Operating Income | $-126M | $-137M | $-118M | |
| Interest Income | $4M | $22.0K | $2M | |
| Other Non-op | $-3M | $-867.0K | $2M | |
| Net Income | $-124M | $-130M | $-117M | |
| EPS (Basic) | $-14.57 | $-176.60 | $-14720.25 | |
| EPS (Diluted) | $-14.57 | $-176.60 | $-14720.25 | |
| Shares (Basic) | 8,511,318 | 736,339 | 7,925 | |
| Shares (Diluted) | 8,511,318 | 736,339 | 7,925 | |
| EBITDA | $-124M | $-133M | $-114M |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $208M | $99M | $25M | |
| Receivables | $6M | $4M | · | |
| Inventory | · | $8M | $14M | |
| Prepaid Expense | $9M | $8M | $9M | |
| Other Current Assets | · | · | $2M | |
| Current Assets | $229M | $119M | $48M | |
| PP&E (Net) | $44M | $42M | $94M | |
| PP&E (Gross) | $50M | $46M | $99M | |
| Accum. Depreciation | $6M | $4M | $5M | |
| Goodwill | · | · | $965.0K | |
| Intangibles | $120.0K | $120.0K | $10M | |
| Other Non-current Assets | $2M | $951.0K | $1M | |
| Total Assets | $277M | $163M | $154M | |
| Accounts Payable | $8M | $5M | $4M | |
| Current Liabilities | $31M | $18M | $19M | |
| Capital Leases | $1M | $358.0K | $632.0K | |
| Total Liabilities | $32M | $23M | $49M | |
| Long-term Debt | · | $9M | $11M | |
| Total Debt | · | $7M | $9M | |
| Common Stock | $13.0K | $4.0K | · | |
| Retained Earnings | $-855M | $-731M | $-601M | |
| AOCI | $-289.0K | $-255.0K | $-232.0K | |
| Stockholders' Equity | $245M | $140M | $106M | |
| Liabilities + Equity | $277M | $163M | $154M | |
| Shares Outstanding | 12,788,069 | 4,385,929 | 20,926 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $3M | $4M | |
| Stock-based Comp | $6M | $5M | $9M | |
| Amort. of Intangibles | $0 | $500.0K | $477.0K | |
| Other Non-cash | $16M | $61M | $1M | |
| Operating Cash Flow | $-100M | $-61M | $-102M | |
| CapEx | $3M | $120.0K | $8M | |
| Investing Cash Flow | $-5M | $-120.0K | $-29M | |
| Net Debt Issued | $-10M | $-2M | · | |
| Stock Issued | $238M | $140M | $19M | |
| Stock Repurchased | $14M | · | $14M | |
| Net Stock Activity | $224M | $140M | $5M | |
| Financing Cash Flow | $215M | $135M | $37M | |
| Net Change in Cash | $110M | $74M | $-95M | |
| Free Cash Flow | $-103M | $-61M | $-110M |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -959.1% | -1354.3% | -1523.9% | |
| Net Margin | -946.2% | -1288.2% | -1501.8% | |
| EBITDA Margin | -944.4% | -1320.4% | -1468.7% | |
| ROA | -56.4% | -82.0% | -61.4% | |
| ROE | -60.0% | -121.7% | -103.1% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.4 | 6.5 | 2.5 | |
| Quick Ratio | 6.9 | 5.6 | 1.3 | |
| Debt / Equity | · | 0.1 | 0.1 | |
| LT Debt / Equity | · | 0.0 | 0.1 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.7 | |
| Receivables Turnover | 2.6 | 5.5 | · |
Stopy Wzrostu 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 29.8% | 29.9% | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $13M | $10M | $8M | |
| Net Income TTM | $-124M | $-130M | $-117M | |
| Market Cap | $200M | $145M | $75.03B | |
| Enterprise Value | · | $53M | $75.01B | |
| P/E | -1.1 | -0.2 | -0.1 | |
| P/S | 15.2 | 14.3 | 9658.4 | |
| P/B | 0.8 | 1.0 | 711.0 | |
| P / Tangible Book | 0.8 | 1.0 | 791.3 | |
| P / Cash Flow | -2.0 | -2.4 | -735.5 | |
| P / FCF | -1.9 | -2.4 | -682.7 | |
| EV / EBITDA | · | -0.4 | -657.5 | |
| EV / FCF | · | -0.9 | -682.5 | |
| EV / Revenue | · | 5.3 | 9656.4 | |
| Earnings Yield | -93.3% | -535.1% | -1150.0% |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $4M | $4M | |
| Cost of Revenue | $2M | $1M | $1M | $3M | $943.0K | $1M | $2M | $3M | $2M | $2M | $2M | |
| R&D Expense | $18M | $17M | $9M | $11M | $7M | $8M | $9M | $10M | $13M | $17M | $21M | |
| SG&A Expense | $29M | $36M | $26M | $16M | $10M | $16M | $8M | $8M | $9M | $12M | $9M | |
| Operating Expenses | $48M | $54M | $36M | $30M | $18M | $25M | $18M | $80M | $24M | $31M | $32M | |
| Operating Income | $-42M | $-48M | $-33M | $-28M | $-16M | $-22M | $-16M | $-77M | $-21M | $-27M | $-28M | |
| Interest Income | $1M | $1M | $1M | · | $394.0K | $1.0K | $18.0K | · | · | · | $172.0K | |
| Other Non-op | $-3.0K | $-578.0K | $-1M | $-2M | · | $376.0K | $-44.0K | $-606.0K | $-593.0K | $7.0K | $172.0K | |
| Net Income | $-40M | $-47M | $-32M | $-28M | $-17M | $-22M | $-14M | $-79M | $-15M | $-27M | $-28M | |
| EPS (Basic) | $-2.93 | $-4.28 | $-3.59 | $-3.86 | $-2.84 | $2302.65 | $-22.68 | $-1920.85 | $-535.72 | $-14629.18 | $-38.63 | |
| EPS (Diluted) | $-2.93 | $-4.28 | $-3.59 | $-3.86 | $-2.84 | $2302.65 | $-22.68 | $-1920.85 | $-535.72 | $-14629.18 | $-38.63 | |
| Shares (Basic) | 13,707,104 | -13,665,962 | 8,922,792 | 7,327,257 | 5,927,231 | 40,773 | 626,669 | 41,011 | 27,886 | -11,560,812 | 724,190 | |
| Shares (Diluted) | 13,707,104 | -13,665,962 | 8,922,792 | 7,327,257 | 5,927,231 | 40,773 | 626,669 | 41,011 | 27,886 | -11,560,812 | 724,190 | |
| EBITDA | $-41M | · | $-33M | $-28M | $-16M | · | $-16M | $-77M | $-20M | · | $-28M |
Bilans 25
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $208M | $190M | $125M | $132M | $99M | $28M | $4M | $7M | $25M | $7M | |
| Receivables | $9M | $6M | $3M | $2M | $3M | $4M | $4M | $3M | · | · | $2M | |
| Inventory | · | · | · | · | · | · | $8M | $9M | $12M | $14M | $13M | |
| Prepaid Expense | $9M | $9M | $9M | $10M | $6M | $8M | $10M | $8M | $11M | $9M | $10M | |
| Other Current Assets | · | · | · | · | · | · | $2M | · | · | · | · | |
| Current Assets | $207M | $229M | $208M | $144M | $150M | $119M | $51M | $25M | $30M | $48M | $31M | |
| PP&E (Net) | $45M | $44M | $43M | $42M | $42M | $42M | $43M | $43M | $93M | $94M | $95M | |
| PP&E (Gross) | $51M | $50M | $48M | $47M | $46M | $46M | $46M | $46M | $99M | $99M | $99M | |
| Accum. Depreciation | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $6M | $5M | $4M | |
| Goodwill | · | · | · | · | · | · | · | · | $965.0K | $965.0K | $965.0K | |
| Intangibles | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $10M | $10M | $10M | |
| Other Non-current Assets | $4M | $2M | $1M | $931.0K | $910.0K | $951.0K | $951.0K | $961.0K | $960.0K | $1M | $1M | |
| Total Assets | $258M | $277M | $252M | $187M | $193M | $163M | $95M | $70M | $135M | $154M | $139M | |
| Accounts Payable | $10M | $8M | $9M | $8M | $4M | $5M | $4M | $10M | $7M | $4M | $8M | |
| Current Liabilities | $30M | $31M | $21M | $19M | $12M | $18M | $15M | $22M | $20M | $19M | $18M | |
| Capital Leases | $1M | $1M | $266.0K | $297.0K | $328.0K | $358.0K | $425.0K | $493.0K | $563.0K | $632.0K | $716.0K | |
| Total Liabilities | $31M | $32M | $21M | $19M | $12M | $23M | $21M | $28M | $27M | $49M | $18M | |
| Long-term Debt | · | · | · | · | · | $9M | $9M | $10M | $11M | $11M | · | |
| Total Debt | · | · | · | · | · | · | $8M | $8M | $9M | · | · | |
| Common Stock | $14.0K | $13.0K | $10.0K | $8.0K | $7.0K | $4.0K | $156.0K | $10.0K | $74.0K | · | $18.0K | |
| Retained Earnings | $-895M | $-855M | $-808M | $-776M | $-748M | $-731M | $-709M | $-694M | $-616M | $-601M | $-573M | |
| AOCI | $-283.0K | $-289.0K | $-274.0K | $-270.0K | $-266.0K | $-255.0K | $-250.0K | $-243.0K | $-240.0K | $-232.0K | $-220.0K | |
| Stockholders' Equity | $227M | $245M | $231M | $168M | $180M | $140M | $74M | $42M | $108M | $106M | $121M | |
| Liabilities + Equity | $258M | $277M | $252M | $187M | $193M | $163M | $95M | $70M | $135M | $154M | $139M | |
| Shares Outstanding | 14,205,401 | 12,788,069 | 10,168,204 | 7,546,276 | 6,877,816 | 4,385,929 | 155,631,049 | 9,832,587 | 73,724,196 | 20,926 | 17,762,341 |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $555.0K | $488.0K | $461.0K | $483.0K | $493.0K | $496.0K | $510.0K | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $2M | $2M | $2M | $1M | $882.0K | $894.0K | $1M | $1M | $2M | $2M | $2M | |
| Amort. of Intangibles | $0 | $0 | $0 | · | $0 | $100.0K | $0 | $200.0K | $200.0K | · | $238.0K | |
| Other Non-cash | $-5M | · | · | · | $-1M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-42M | $-40M | $-29M | $-15M | $-17M | $-15M | $-19M | $-10M | $-18M | $-22M | $-23M | |
| CapEx | $2M | $2M | $962.0K | $527.0K | $6.0K | $3.0K | $9.0K | $0 | $108.0K | $438.0K | $2M | |
| Investing Cash Flow | $-2M | $-1M | $-962.0K | $-3M | $-6.0K | $-3.0K | $-9.0K | $0 | $-108.0K | $-431.0K | $-821.0K | |
| Net Debt Issued | · | · | · | · | $-10M | · | · | · | $-235.0K | · | · | |
| Stock Issued | $20M | $67M | $95M | $14M | $62M | $86M | $44M | · | · | $9M | $6M | |
| Stock Repurchased | · | $8M | $0 | $3M | $3M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | $20M | · | · | $-3M | $59M | · | · | · | · | · | · | |
| Financing Cash Flow | $20M | $59M | $95M | $11M | $50M | $85M | $43M | $7M | $-212.0K | $41M | $6M | |
| Net Change in Cash | $-24M | $18M | $65M | $-6M | $33M | $71M | $24M | $-3M | $-18M | $18M | $-18M | |
| Free Cash Flow | $-44M | · | · | · | $-17M | · | · | · | $-18M | · | · |
Rentowność 5
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -603.9% | · | -1005.1% | -1416.2% | -660.9% | · | -551.2% | -3501.6% | -860.2% | · | -705.6% | |
| Net Margin | -584.4% | · | -972.9% | -1415.0% | -692.8% | · | -503.7% | -3567.8% | -601.9% | · | -701.3% | |
| EBITDA Margin | -595.8% | · | -1005.1% | -1416.2% | -640.6% | · | -551.2% | -3501.6% | -811.5% | · | -705.6% | |
| ROA | -17.8% | · | -18.4% | -21.9% | -10.2% | · | -12.1% | -68.5% | -9.5% | · | -14.6% | |
| ROE | -19.7% | · | -21.0% | -26.9% | -11.7% | · | -14.6% | -86.3% | -10.9% | · | -16.0% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 9.9 | 7.5 | 12.3 | · | 3.3 | 1.1 | 1.5 | · | 1.8 | |
| Quick Ratio | 6.6 | · | 9.2 | 6.7 | 11.1 | · | 2.1 | 0.3 | 0.3 | · | 0.5 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | 0.1 | · | · |
Efektywność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | 0.1 | 0.3 | 0.3 | · | 0.4 | |
| Receivables Turnover | 1.1 | · | 0.9 | 0.7 | 1.5 | · | 1.0 | 1.3 | · | · | 5.1 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15M | · | $11M | $9M | $10M | · | $12M | · | · | · | · | |
| Net Income TTM | $-117M | · | $-91M | $-138M | $-125M | · | $-136M | $-150M | $-104M | · | $-118M | |
| Market Cap | $195M | · | $246M | $272M | $123M | · | $2.33B | $688M | $44.82B | · | $31.26B | |
| Enterprise Value | · | · | · | · | · | · | $2.31B | $693M | $44.83B | · | · | |
| P/E | -1.0 | · | -0.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -1.0 | · | -18.5 | |
| P/S | 13.4 | · | 23.3 | 28.7 | 12.4 | · | 203.0 | · | · | · | · | |
| P/B | 0.9 | · | 1.1 | 1.6 | 0.7 | · | 31.5 | 16.3 | 414.5 | · | 258.7 | |
| P / Tangible Book | 0.9 | · | 1.1 | 1.6 | 0.7 | · | 31.5 | 16.4 | 458.9 | · | 284.5 | |
| P / Cash Flow | -4.6 | · | · | · | -7.4 | · | · | · | -2550.5 | · | · | |
| P / FCF | -4.4 | · | · | · | -7.4 | · | · | · | -2534.9 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | -148.8 | -9.0 | -2225.6 | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | -2535.0 | · | · | |
| EV / Revenue | · | · | · | · | · | · | 201.2 | · | · | · | · | |
| Earnings Yield | -96.2% | · | -136.5% | -5420.3% | -13881.9% | · | -16785.9% | -3634.9% | -103.1% | · | -5.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $13M | $10M | $8M | — | — |
| Marża Operacyjna % | -959.1% | -1354.3% | -1523.9% | — | — |
| Zysk netto | $-124M | $-130M | $-117M | $-110M | $-92M |
| Rozwodniony EPS | $-14.57 | $-176.60 | $-14720.25 | $-20.01 | $-8.10 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | 0.1 | 0.1 | — | — |
| Wskaźnik bieżący | 7.4 | 6.5 | 2.5 | 7.2 | 8.7 |
| Wskaźnik Szybkości | 6.9 | 5.6 | 1.3 | 6.6 | 8.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-103M | $-61M | $-110M | $-146M | $-111M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.